INTERNATIONAL PATENT: PFIZER INC., REMEGEN CO., LTD. FILES APPLICATION FOR "COMBINATION THERAPY USING CDK4 INHIBITORS FOR CANCER TREATMENTS"

GENEVA, Feb. 4 -- PFIZER INC. (66 Hudson Boulevard EastAttn: Legal Patent DepartmentNew York, New York 10001-2192), REMEGEN CO., LTD. (58 Beijing Middle RoadYantai, Shandong) filed a patent application (PCT/US2025/039221) for "COMBINATION THERAPY USING CDK4 INHIBITORS FOR CANCER TREATMENTS" on Jul 25, 2025. With publication no. WO/2026/025013, the details related to the patent application was published on Jan 29, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ANDERS, Lars (c/o Pfizer Inc.66 Hudson Boulevard EastNew York, New York 10001-2192), LI, Danan (c/o Pfizer Inc.66 Hudson Boulevard Ea...